Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain - PubMed
- ️Thu Jan 01 2009
Mechanisms of antagonism of the GluR2 AMPA receptor: structure and dynamics of the complex of two willardiine antagonists with the glutamate binding domain
Ahmed H Ahmed et al. Biochemistry. 2009.
Abstract
Ionotropic glutamate receptors mediate the majority of vertebrate excitatory synaptic transmission. The development of selective antagonists for glutamate receptor subtypes is of interest in the treatment of a variety of neurological disorders. This study presents the crystal structure of the binding domain of GluR2 bound to two antagonists (UBP277 and UBP282) that are derivatives of the natural product, willardiine. The antagonists bind to one lobe of the protein with interactions similar to agonists. Interaction with the second lobe differs between the two antagonists, resulting in a different position of the uracil ring and different orientations of the bilobed structure. UBP277 binding produces a stable lobe orientation that is similar to the apo state, but the binding of UBP282 produces the largest hyperextension of the lobes yet reported for an AMPA receptor. The carboxyethyl (UBP277) and carboxybenzyl (UBP282) substituents in the N(3) position keep the lobes separated by a "foot-in-the-door" mechanism and the internal dynamics are minimal compared to the CNQX-bound form of the protein (which makes minimal contacts with one of the two lobes). In contrast to the antagonists CNQX and DNQX, UBP277 and UBP282 produce complexes with higher thermal stability, but affinities that are more than 100-fold lower. These structures support the idea that antagonism is associated with the overall orientation of the lobes rather than with specific interactions, and antagonism can rise either from specific interactions with both lobes ("foot-in-the-door" mechanism) or from the lack of extensive interactions with one of the two lobes.
Figures
![Figure 1](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1c/2693247/b3069f7916d2/nihms-109460-f0001.gif)
Structures of the binding sites for UBP277 (A) and UBP282 (B) on GluR2 S1S2. In each case, Lobe 1 is shown in cyan and Lobe 2 in green. Interactions between the ligand and protein sidechains are indicated. Additional interactions with the backbone are also made with Lobe 1.
![Figure 2](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1c/2693247/a2bed00e6a78/nihms-109460-f0002.gif)
The orientation of different willardiines in the GluR2 S1S2 binding site is illustrated. The residues in Lobe 1 were aligned. The positions of HW (red; 1mqj), BrW (green, 1mqh) and FW (black, 1mqi) are superimposable. However, the positions of IW (blue, 1mqg) varies within the same crystal. IW is the lowest efficacy of the four partial agonists. UBP277 (yellow) and UBP282 (cyan) move even further down the binding pocket than IW and make contact with Lobe 2 through the substituents in the 2 position.
![Figure 3](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1c/2693247/0087510604cc/nihms-109460-f0003.gif)
(A) Structures of the antagonists used in the binding study. (B) Inhibition of the binding of [3H]AMPA to GluR2 S1S2 by DNQX, CNQX, UBP277, and UBP282. The IC50 values were: 0.38 ± 0.04 μM, 0.68 ± 0.06 μM, 135 ± 12 μM, 292 ± 26 μM, respectively.
![Figure 4](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1c/2693247/b9c71637ccf7/nihms-109460-f0004.gif)
19F NMR spectra of antagonists bound to 5-19F-tryptophan-labeled GluR2 S1S2 as a function of temperature: (A) CNQX, (B) DNQX, (C) UBP277, and (D) UBP282. The signal for W767 is in chemical exchange for the CNQX-bound form but apparently not for S1S2 bound to the other three antagonists. Two additional peaks (marked with asterisks) were consistently seen in spectra of the UBP282-bound form and are consistent with chemical shifts observed in the apo form.
![Figure 5](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1c/2693247/20c2dd3c56fe/nihms-109460-f0005.gif)
(A) A portion of the 1H,15N-HSQC (TROSY) spectrum at 10°C showing the sidechain tryptophan amides for GluR2 S1S2 bound to a variety of willardiine agonists and antagonists as well as CNQX and DNQX. The signal for W767 varies with the orientation of the two lobes, moving upfield as the lobe opening increases. The amide proton makes a hydrogen bond across the lobe interface with the carbonyl of T707, shown here in the UBP277-S1S2 structure (B). The peak for this correlation is dramatically broadened at this temperature for IW and CNQX, but not the other compounds shown. This broadening is consistent with exchange between multiple relative orientations of the two lobes (10).
![Figure 6](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1c/2693247/016f26b4928f/nihms-109460-f0006.gif)
(A & B) Sample data from ITC competitive binding studies: 500 μM UBP277 titrated into 12 μM S1S2 bound to glutamate at 10°C. The data were fit using Origin 7 and the equations described by Sigurskjold et al. (33) for competition binding. (C & D) Schematic of the relative enthalpies and entropies of binding of various ligands to S1S2 as determined by competitive binding ITC experiments.
![Figure 7](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1c/2693247/dcacc343dcb5/nihms-109460-f0007.gif)
Thermal denaturation of GluR2-S1S2 bound to glutamate, CNQX, DNQX, UBP277 and UBP282. The temperature was increased at a rate of 0.06 min/°C. The data were fit as described by Madden et al. (34).
![Figure 8](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5e1c/2693247/9e802596cf45/nihms-109460-f0008.gif)
(A) Ribbon structures of GluR2-S1S2 bound to CNQX (purple, 3b7d, 17), DNQX (brown, 1ftl, 15), UBP277 (yellow), and UBP282 (cyan). The residues in Lobe 1 are aligned to illustrate the different lobe orientations. Using DynDom (41), the lobe opening relative to the glutamate-bound form (1ftj, C protomer, 15) is 15.7° ± 0.5° for CNQX, 16.5° ± 1.1° for DNQX, 19.8° ± 0.6° for UBP277, and 26.7° ± 1.8° for UBP282. (B) Overlay of the binding site for six antagonists showing the multiple sites of interaction. Shown are CNQX, DNQX, UBP277, UBP282 (as in part A), ATPO (orange, 1n0t, 16), and NS1209 (green, 2cmo, 18). As in part A, the residues in Lobe 1 were aligned.
Similar articles
-
More JC, Troop HM, Dolman NP, Jane DE. More JC, et al. Br J Pharmacol. 2003 Mar;138(6):1093-100. doi: 10.1038/sj.bjp.0705148. Br J Pharmacol. 2003. PMID: 12684265 Free PMC article.
-
Mayer ML, Ghosal A, Dolman NP, Jane DE. Mayer ML, et al. J Neurosci. 2006 Mar 15;26(11):2852-61. doi: 10.1523/JNEUROSCI.0123-06.2005. J Neurosci. 2006. PMID: 16540562 Free PMC article.
-
Kasper C, Pickering DS, Mirza O, Olsen L, Kristensen AS, Greenwood JR, Liljefors T, Schousboe A, Wätjen F, Gajhede M, Sigurskjold BW, Kastrup JS. Kasper C, et al. J Mol Biol. 2006 Apr 7;357(4):1184-201. doi: 10.1016/j.jmb.2006.01.024. Epub 2006 Jan 31. J Mol Biol. 2006. PMID: 16483599
-
The biochemistry, ultrastructure, and subunit assembly mechanism of AMPA receptors.
Nakagawa T. Nakagawa T. Mol Neurobiol. 2010 Dec;42(3):161-84. doi: 10.1007/s12035-010-8149-x. Epub 2010 Nov 16. Mol Neurobiol. 2010. PMID: 21080238 Free PMC article. Review.
-
The AMPA receptor binding site: focus on agonists and competitive antagonists.
Stensbøl TB, Madsen U, Krogsgaard-Larsen P. Stensbøl TB, et al. Curr Pharm Des. 2002;8(10):857-72. doi: 10.2174/1381612024607090. Curr Pharm Des. 2002. PMID: 11945136 Review.
Cited by
-
Ahmed AH, Ptak CP, Oswald RE. Ahmed AH, et al. Biochemistry. 2010 Apr 6;49(13):2843-50. doi: 10.1021/bi1000678. Biochemistry. 2010. PMID: 20199107 Free PMC article.
-
Park JS, Wang C, Han Y, Huang Z, Niu L. Park JS, et al. J Biol Chem. 2011 Apr 29;286(17):15608-17. doi: 10.1074/jbc.M111.229559. Epub 2011 Mar 14. J Biol Chem. 2011. PMID: 21402710 Free PMC article.
-
Ramaswamy S, Cooper D, Poddar N, MacLean DM, Rambhadran A, Taylor JN, Uhm H, Landes CF, Jayaraman V. Ramaswamy S, et al. J Biol Chem. 2012 Dec 21;287(52):43557-64. doi: 10.1074/jbc.M112.371815. Epub 2012 Oct 31. J Biol Chem. 2012. PMID: 23115239 Free PMC article.
-
Ahmed AH, Wang S, Chuang HH, Oswald RE. Ahmed AH, et al. J Biol Chem. 2011 Oct 7;286(40):35257-66. doi: 10.1074/jbc.M111.269001. Epub 2011 Aug 16. J Biol Chem. 2011. PMID: 21846932 Free PMC article.
-
Martinez M, Ahmed AH, Loh AP, Oswald RE. Martinez M, et al. Biochemistry. 2014 Jun 17;53(23):3790-5. doi: 10.1021/bi500511m. Epub 2014 Jun 5. Biochemistry. 2014. PMID: 24850223 Free PMC article.
References
-
- Dingledine R, Borges K, Bowie D, Traynelis S. The glutamate receptor ion channels. Pharmacol. Rev. 1999;51:7–61. - PubMed
-
- Asztely F, Gustafsson B. Ionotropic glutamate receptors. Their possible role in the expression of hippocampal synaptic plasticity. Mol Neurobiol. 1996;12:1–11. - PubMed
-
- Mayer ML. Glutamate receptors at atomic resolution. Nature. 2006;440:456–462. - PubMed
-
- Jin R, Horning M, Mayer ML, Gouaux E. Mechanism of activation and selectivity in a ligand-gated ion channel: structural and functional studies of GluR2 and quisqualate. Biochemistry. 2002;41:15635–15643. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- BB/C507045/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- BB/F012519/1/BB_/Biotechnology and Biological Sciences Research Council/United Kingdom
- R01 GM068935-04/GM/NIGMS NIH HHS/United States
- G0601812/MRC_/Medical Research Council/United Kingdom
- P41 RR001646/RR/NCRR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources